This inventor holds 1 USPTO granted patent. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: David C Hanley, Sr: Innovator in Pharmaceutical Compositions
Introduction
David C Hanley, Sr. is a notable inventor based in Brookfield, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug stability and efficacy.
Latest Patents
Hanley holds a patent for "Clevidipine nanoparticles and pharmaceutical compositions thereof." This patent describes a pharmaceutical composition that includes clevidipine in a sterile, ready-to-use, physically stable, aqueous dispersion of nanoparticles. This formulation stabilizes clevidipine against the formation of impurities and is suitable for parenteral administration. He has 1 patent to his name.
Career Highlights
Throughout his career, Hanley has worked with Chiesi Farmaceutici S.p.a., a company known for its commitment to developing innovative pharmaceutical solutions. His work has focused on improving drug formulations to enhance patient outcomes.
Collaborations
Hanley has collaborated with talented professionals in his field, including Rajeshwar Motheram and Akif Emre Tureli. These collaborations have contributed to the advancement of pharmaceutical technologies.
Conclusion
David C Hanley, Sr. is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the medical field. His innovative approach to drug formulation exemplifies the importance of research and development in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile